Available individually, as sub groups or as a company share sale. Download Portfolio Overview in PDF format
To access further information, please enter your details here:
Sign me in automatically
Sign in here
Please read NDA to proceed
Strictly Private & Confidential
You have expressed an interest in Project Medipharmacy (the Transaction). As agent for the vendors (the Sellers), we are prepared to make available to you certain confidential information about the Transaction. This confidentiality agreement relates to information at any time and from time to time supplied by us or by any of our Connected Persons orally, in writing or in any other form to you or your Authorised Recipients in connection with the Transaction (the Information).
In this confidentiality agreement, our Connected Persons means, in each case at any time during which the provisions of this confidentiality agreement apply, (a) the Sellers and their and our respective officers, employees, advisers, agents and representatives; (b) each of the Sellers' and our respective group undertakings and their respective officers, employees, advisers, agents and representatives; and (c) officers, employees and partners of any such adviser, agent or representative or of their respective group undertakings.
group undertaking shall be construed in accordance with s1161 of the Companies Act 2006.
In consideration of our disclosing the Information to you, you agree with and undertake to us as follows. The undertakings in this confidentiality agreement are given in our favour and in favour of our Connected Persons. The rights of our Connected Persons to enforce the terms of this confidentiality agreement are subject to the provisions of paragraph 13 (Third Party Rights).
You will hold the Information in strict confidence and will not disclose, copy, reproduce or distribute any of it to any person other than as permitted in writing by the Sellers or to those of your officers, employees, group undertakings, agents, funders and advisers and the officers, employees and advisers of any of those group undertakings who strictly need access to it for the purposes of furthering the Transaction (your Authorised Recipients), and only to the extent that they need that access, on the terms of this confidentiality agreement and on the basis that they themselves will not disclose, copy, reproduce or distribute it to any person who is not an Authorised Recipient.
Neither you nor any of your Authorised Recipients will, without the Sellers’ prior written consent:
reveal to any person other than an Authorised Recipient that negotiations are taking place in relation to the Transaction or any information concerning the status or progress of such negotiations; or
use the Information for any purpose other than to evaluate the Transaction; in particular you will not use the Information in the future conduct of your trading operations except where our discussions result in you buying any Pharmacy from Project Medipharmacy.The undertakings in paragraphs 1 and 2 above will not apply to Information which:
at the time of supply is in the public domain; or
subsequently comes into the public domain, except through breach of the undertakings set out in this confidentiality agreement; or
is in your lawful possession or that of an Authorised Recipient prior to the date of this confidentiality agreement (as evidenced by written records); or
subsequently comes lawfully into your possession or that of an Authorised Recipient from a third party who does not owe us or any of our Connected Persons an obligation of confidence in relation to it; or
is required to be disclosed by law, regulation or any governmental or competent regulatory authority, as long as you or the Authorised Recipient making such disclosure consults the Sellers first on the proposed form, timing, nature and purpose of the disclosure; or
if the Transaction is implemented by you, relates solely to the purchase of any pharmacy from Project Medipharmacy.
You will procure so far as you are legally able that each of your Authorised Recipients who receives any Information is aware of and adheres to the terms of this confidentiality agreement. On request, you will keep us informed of their identity. The undertakings in this confidentiality agreement are given by you on your own behalf and as agent for each of your Authorised Recipients, and with their full knowledge and authority. You will indemnify and hold each of the Sellers and each of our other Connected Persons harmless, on an aftertax basis, from and against all claims, demands, liabilities, losses, damages, costs and expenses suffered or incurred by the Sellers or any of our other Connected Persons arising directly or indirectly from a breach of this confidentiality agreement by you or any of your Authorised Recipients.
You and your Authorised Recipients will destroy or return to us on demand any document (including any note, analysis or memorandum prepared by any of you) containing Information and any copy which may have been made and take reasonable steps to expunge all Information from any computer, word processor or other device containing Information. Any destruction of Information will be certified in writing to us by an authorised officer supervising it. The undertakings in this paragraph shall not apply to Information which you or an Authorised Recipient must retain under any applicable law, rule or regulation, including the rules of a professional body.
directly or indirectly make or have any contact whatsoever in relation to any pharmacy from Project Medipharmacy or the Transaction with any officer or employee of the Sellers or any of its group undertakings or any person who has been a customer or supplier, contractor or sub-contractor of or to any of them in relation to any pharmacy from Project Medipharmacy in the 12 months preceding the date of this confidentiality agreement (except to the extent that our discussions result in you buying to any pharmacy from Project Medipharmacy); or
for a period of one year after the date of this confidentiality agreement, solicit, endeavour to entice away, employ or offer to employ directly or indirectly any officer or senior executive of the Sellers or any of their respective group undertakings.
You understand that the Information does not purport to be all inclusive and that no representation or warranty is made as to the accuracy, reliability or completeness of any of the Information. Accordingly you agree with us and with each of our Connected Persons that neither we nor any of our Connected Persons shall have any liability to you or any other person resulting from the use of Information by you and/or them and, without prejudice to the generality of the foregoing, that you and your Authorised Recipients will be bound by the terms of any disclaimer of liability on our part and/or on the part of any of our Connected Persons subject to which the Information Memorandum may be issued and that the terms of this disclaimer may not be terminated or rescinded or varied without the prior written consent of our Connected Persons. This paragraph will not exclude any liability for, or remedy in respect of, fraudulent misrepresentation.
Save as expressly set out in this confidentiality agreement, neither we nor any of our Connected Persons shall owe any duty of care to you, any of your Authorised Recipients, or any other person.
Nothing in this confidentiality agreement will prevent you or the Sellers from disclosing information in relation to the Transaction to your or its employees or the employees of your or its respective group undertakings or to representatives of such employees in accordance with any applicable procedure for informing and consulting employees, provided that such employees or representatives are required to keep that information strictly confidential and that you take all reasonable steps to disclose only the minimum amount of information required to comply with such procedure.
Without affecting any other rights or remedies that they may have, you acknowledge that a person with rights under this confidentiality agreement may be irreparably harmed by any breach of its terms and that damages alone may not necessarily be an adequate remedy. Accordingly, a person bringing a claim under this confidentiality agreement will be entitled to the remedies of injunction, specific performance and other equitable relief, or any combination of these remedies, for any threatened or actual breach of its terms, and no proof of special damages will be necessary to enforce this confidentiality agreement.
You acknowledge and agree that the undertakings set out in this confidentiality agreement will survive completion of negotiations, whether or not the Transaction is implemented. Except in the case of paragraph 6(b), such undertakings shall survive for a fixed period of two years from the date of this confidentiality agreement.
If any provision of this confidentiality agreement is held to be invalid or unenforceable, that provision shall (so far as it is invalid or unenforceable) be given no effect and shall be deemed not to be included in this confidentiality agreement, but without invalidating any of the remaining provisions.
A failure to exercise or delay in exercising any right or remedy provided by this confidentiality agreement or by law does not constitute a waiver of that or any other right or remedy, and no single or partial exercise of a right or remedy will preclude any further exercise of any such right or remedy.
Each of our Connected Persons shall have the right under the Contracts (Rights of Third Parties) Act 1999 to enforce the terms of this confidentiality agreement (as amended from time to time), subject to and in accordance with the terms of paragraph 16 (Governing Law and Jurisdiction). The parties to this confidentiality agreement may by agreement terminate or rescind or vary it in any way without the consent of any of our Connected Persons, save that the consent of the Sellers shall be required for any such termination, rescission or variation.
Save as provided in paragraph 13, a person who is not a party to this confidentiality agreement shall have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any of its terms.
This confidentiality agreement may be executed by the parties in separate counterparts, which shall together constitute one confidentiality agreement.
This confidentiality agreement, the relationship between the parties and the conduct of the procedure for the sale by us of to any pharmacy from Project Medipharmacy shall be governed by, and construed in accordance with, English law, and each party irrevocably submits to the exclusive jurisdiction of the English courts.
Christie & Co is registered under the Data Protection Act 1998 and General Data Protection Regulation 2016 (“GDPR”) under registration number Z8293541. All Personal Data about you will be treated as private and confidential. The Christie Group will use the Personal Data supplied by you only for purposes associated with legitimate business interests such as the administration of the (potential) business relationship. We follow the rules of GDPR and the terms of our registration when dealing with your Personal Data and we have a formal complaints procedure, a copy of which is available on request or on our website at https://www.christie.com/complaints/
By clicking on the "Accept" button below, I acknowledge that I have read, understood and agree, on my own behalf and on behalf of the organisation I represent, to the above Terms and Conditions.
Terms and Conditions
Privacy & Cookies